Deschloroclotizolam | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 314.8 g/mol [1] |
Predicted LogP | 2.1 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C15H11ClN4S [1] |
IUPAC name | 4-chloro-13-methyl-7-phenyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene [1] |
SMILES | CC1=NN=C2N1C3=C(C=C(S3)Cl)C(=NC2)C4=CC=CC=C4 [1] |
InChI | InChI=1S/C15H11ClN4S/c1-9-18-19-13-8-17-14(10-5-3-2-4-6-10)11-7-12(16)21-15(11)20(9)13/h2-7H,8H2,1H3 [1] |
InChIKey | DBAZIULAFZCKIM-UHFFFAOYSA-N [1] |
Deschloroclotizolam
Deschloroclotizolam (also known as 2-Chloro-9-methyl-4-phenyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine or 6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 2-chloro-9-methyl-4-phenyl-) is a
Chemistry
Stereochemistry []
Deschloroclotizolam is a achiral mixture
Legal status
- Canada: Deschloroclotizolam is a Schedule IV substance.
- Germany: Deschloroclotizolam is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Deschloroclotizolam is a Schedule 1 substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 157010678, Deschloroclotizolam. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/157010678
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Deschloroclotizolam. UNII: 5UY5T8AK63. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5UY5T8AK63